title: New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids.
authors.affiliation: Department of Adult Psychiatry, Cleveland Clinic, Cleveland, OH.
authors.forename: Neil A
authors.initials: NA
authors.lastname: Patel
authors.affiliation: Cleveland Clinic Alcohol and Drug Recovery Center, Cleveland Clinic Lutheran Hospital, Cleveland, OH; Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH.
authors.forename: Jason M
authors.initials: JM
authors.lastname: Jerry
authors.affiliation: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH; Consultation-Liaison Psychiatry, Cleveland Clinic, Cleveland, OH.
authors.forename: Xavier F
authors.initials: XF
authors.lastname: Jimenez
authors.affiliation: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic, Cleveland, OH; Epilepsy Center, Cleveland Clinic, Cleveland, OH.
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Hantus
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D002186:Cannabinoids / Q000633:toxicity*; D015198:Designer Drugs / Q000633:toxicity*; D000069279:Drug Resistant Epilepsy / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D004569:Electroencephalography; D006801:Humans; D008297:Male; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D013226:Status Epilepticus / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000150:complications*; D055815:Young Adult
chemical_list: D000927:Anticonvulsants; D002186:Cannabinoids; D015198:Designer Drugs